Answers are grounded in this paper and cite their sources.
Long-term follow-up demonstrates treatment efficacy for telangiectasias and reticular veins, supporting clinical viability.
Telangiectasia recurrence was common after 3 years, regardless of treatment. In contrast, reticular veins showed minimal recurrence, particularly with PDHG. Pigmentation generally resolved spontaneously. Matting was more persistent in telangiectasias than in reticular veins. These findings support the long-term viability of both approaches in clinical practice.
No takes yet. Share an insight, caveat, or question.
Bertanha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: